Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Golimumab> ?p ?o. }
Showing items 1 to 64 of
64
with 100 items per page.
- Golimumab abstract "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Golimumab has been approved in 2013 for use in adults with moderately to severely active Ulcerative Colitis. In the same year, Johnson & Johnson, the parent company of Centocor, also received an approval from European Medicines Agency (EMEA) for the use of golimumab as a treatment for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Golimumab is marketed by Merck & Co, Inc. in Europe, pending final arbitration between J&J and Merck.".
- Golimumab atcPrefix "L04".
- Golimumab atcSuffix "AB06".
- Golimumab casNumber "476181-74-5".
- Golimumab fdaUniiCode "91X1KLU43E".
- Golimumab wikiPageExternalLink article.php?article_id=7069.
- Golimumab wikiPageID "9133439".
- Golimumab wikiPageRevisionID "599629851".
- Golimumab atcPrefix "L04".
- Golimumab atcSuffix "AB06".
- Golimumab c "6530".
- Golimumab casNumber "476181".
- Golimumab chembl "1201833".
- Golimumab chemspiderid "NA".
- Golimumab h "10068".
- Golimumab hasPhotoCollection Golimumab.
- Golimumab kegg "D04358".
- Golimumab legalUs "Rx-only".
- Golimumab licenceEu "Simponi".
- Golimumab licenceUs "Golimumab".
- Golimumab mabType "mab".
- Golimumab medlineplus "a610010".
- Golimumab molecularWeight "147".
- Golimumab n "1752".
- Golimumab o "2026".
- Golimumab routesOfAdministration Subcutaneous_injection.
- Golimumab s "44".
- Golimumab source "u".
- Golimumab target TNFα.
- Golimumab tradename "Simponi".
- Golimumab type "mab".
- Golimumab unii "91".
- Golimumab verifiedfields "changed".
- Golimumab verifiedrevid "458275071".
- Golimumab subject Category:Centocor.
- Golimumab subject Category:Johnson_&_Johnson.
- Golimumab subject Category:TNF_inhibitors.
- Golimumab type Inhibitor114724436.
- Golimumab type Matter100020827.
- Golimumab type PhysicalEntity100001930.
- Golimumab type Substance100020090.
- Golimumab type TNF-alphaInhibitors.
- Golimumab type Drug.
- Golimumab type DrugProduct.
- Golimumab type FunctionalSubstance.
- Golimumab comment "Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.Golimumab was developed by Centocor and is approved in Canada and the United States as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.".
- Golimumab label "Golimumab".
- Golimumab label "Golimumab".
- Golimumab label "Golimumab".
- Golimumab label "Golimumab".
- Golimumab label "Golimumab".
- Golimumab label "غوليموماب".
- Golimumab label "ゴリムマブ".
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs Golimumab.
- Golimumab sameAs ゴリムマブ.
- Golimumab sameAs m.027yxww.
- Golimumab sameAs Q413879.
- Golimumab sameAs Q413879.
- Golimumab sameAs Golimumab.
- Golimumab wasDerivedFrom Golimumab?oldid=599629851.
- Golimumab isPrimaryTopicOf Golimumab.